FLGT (Fulgent Genetics, Inc. Common Stock) Stock Analysis - Insider Trades
Fulgent Genetics, Inc. Common Stock (FLGT) is a publicly traded Healthcare sector company. As of May 21, 2026, FLGT trades at $16.42 with a market cap of $450.15M and a P/E ratio of 0.00. FLGT moved +2.92% today. Year to date, FLGT is -35.32%; over the trailing twelve months it is -22.67%. Its 52-week range spans $13.46 to $31.04. Analyst consensus is buy with an average price target of $18.50. Rallies surfaces FLGT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading FLGT stock inside the company?
Recent FLGT insider activity includes Xie Jian sold 1.14K, Gao Hanlin sold 1.07K, Xie Jian sold 1.20K, Gao Hanlin sold 943, and Xie Jian sold 681. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Recent FLGT insider activity includes Xie Jian sold 1.14K, Gao Hanlin sold 1.07K, Xie Jian sold 1.20K, Gao Hanlin sold 943, and Xie Jian sold 681. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for FLGT?
Yes. Rallies tracks FLGT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is FLGT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for FLGT. It does not provide personalized investment advice.